中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2013年
2期
409-410
,共2页
吾米提汗?热合曼%向志勇
吾米提汗?熱閤曼%嚮誌勇
오미제한?열합만%향지용
急性重症胰腺炎%血液滤过%血液灌流%临床观察
急性重癥胰腺炎%血液濾過%血液灌流%臨床觀察
급성중증이선염%혈액려과%혈액관류%림상관찰
Severe acute pancreatitis%Hemofiltration%Hemoperfusion%Clinical observation
目的急性重症胰腺炎早期血液滤过联合血液灌流治疗的临床观察.方法回顾性分析来我院就诊的26例急性重症胰腺炎患者的临床资料.所有患者在给予常规治疗的基础上,采用血液滤过联合血液灌流治疗.观察治疗前后患者的呼吸、脉搏、血压以及血尿淀粉酶等实验室指标.结果26例患者治疗后心动过速、发热、低氧血症、酸中毒等症状明显缓解,患者的腹膜刺激征、腹痛症状好转,有肾脏功能衰竭合并症者在7至9天进入多尿期.所有患者在治疗期间没有严重的不良反应.结论急性重症胰腺炎早期采用血液滤过联合血液灌流治疗的临床疗效非常显著,是重要的治疗措施.
目的急性重癥胰腺炎早期血液濾過聯閤血液灌流治療的臨床觀察.方法迴顧性分析來我院就診的26例急性重癥胰腺炎患者的臨床資料.所有患者在給予常規治療的基礎上,採用血液濾過聯閤血液灌流治療.觀察治療前後患者的呼吸、脈搏、血壓以及血尿澱粉酶等實驗室指標.結果26例患者治療後心動過速、髮熱、低氧血癥、痠中毒等癥狀明顯緩解,患者的腹膜刺激徵、腹痛癥狀好轉,有腎髒功能衰竭閤併癥者在7至9天進入多尿期.所有患者在治療期間沒有嚴重的不良反應.結論急性重癥胰腺炎早期採用血液濾過聯閤血液灌流治療的臨床療效非常顯著,是重要的治療措施.
목적급성중증이선염조기혈액려과연합혈액관류치료적림상관찰.방법회고성분석래아원취진적26례급성중증이선염환자적림상자료.소유환자재급여상규치료적기출상,채용혈액려과연합혈액관류치료.관찰치료전후환자적호흡、맥박、혈압이급혈뇨정분매등실험실지표.결과26례환자치료후심동과속、발열、저양혈증、산중독등증상명현완해,환자적복막자격정、복통증상호전,유신장공능쇠갈합병증자재7지9천진입다뇨기.소유환자재치료기간몰유엄중적불량반응.결론급성중증이선염조기채용혈액려과연합혈액관류치료적림상료효비상현저,시중요적치료조시.
Objective Clinical observation of severe acute pancreatitis early hemofiltration combined with hemoperfusion treatment. Methods Aretrospective analysis of clinical data in our hospital for treatment of 26 cases of patients with severe acute pancreatitis.Al the patients received routine treatment, using hemofiltration combined with hemoperfusion.The patient's respiratory, pulse, blood pressure and urine amylase laboratory indexes were observed before and after treatment. Results 26 patients after treatment with heartbeat tachycardia, fever, hypoxemia, acidosis and other symptoms, patients with peritoneal irritation sign, abdominal pain symptoms improved, a disease associated with kidney failure in polyuria period in 7 to 9 days.Al patients had no serious adverse reactions during treatment. Conclusion The therapeutic effect of severe acute pancreatitis by early hemofiltration combined with hemoperfusion in the treatment of very significant, is the important measures of treatment.